ANGO
Price
$12.30
Change
-$0.36 (-2.84%)
Updated
Nov 13 closing price
Capitalization
506.76M
48 days until earnings call
Intraday BUY SELL Signals
MLSS
Price
$0.36
Change
-$0.02 (-5.26%)
Updated
Nov 14, 01:14 PM (EDT)
Capitalization
29.83M
133 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANGO vs MLSS

Header iconANGO vs MLSS Comparison
Open Charts ANGO vs MLSSBanner chart's image
AngioDynamics
Price$12.30
Change-$0.36 (-2.84%)
Volume$290.76K
Capitalization506.76M
Milestone Scientific
Price$0.36
Change-$0.02 (-5.26%)
Volume$20.18K
Capitalization29.83M
ANGO vs MLSS Comparison Chart in %
ANGO
Daily Signal:
Gain/Loss:
MLSS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ANGO vs. MLSS commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANGO is a Hold and MLSS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (ANGO: $12.30 vs. MLSS: $0.38)
Brand notoriety: ANGO and MLSS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ANGO: 56% vs. MLSS: 3912%
Market capitalization -- ANGO: $506.76M vs. MLSS: $29.83M
ANGO [@Pharmaceuticals: Other] is valued at $506.76M. MLSS’s [@Pharmaceuticals: Other] market capitalization is $29.83M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $200.47B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANGO’s FA Score shows that 0 FA rating(s) are green whileMLSS’s FA Score has 0 green FA rating(s).

  • ANGO’s FA Score: 0 green, 5 red.
  • MLSS’s FA Score: 0 green, 5 red.
According to our system of comparison, ANGO is a better buy in the long-term than MLSS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANGO’s TA Score shows that 4 TA indicator(s) are bullish while MLSS’s TA Score has 3 bullish TA indicator(s).

  • ANGO’s TA Score: 4 bullish, 4 bearish.
  • MLSS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ANGO is a better buy in the short-term than MLSS.

Price Growth

ANGO (@Pharmaceuticals: Other) experienced а +4.86% price change this week, while MLSS (@Pharmaceuticals: Other) price change was -2.65% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.44%. For the same industry, the average monthly price growth was +1.60%, and the average quarterly price growth was +7.03%.

Reported Earning Dates

ANGO is expected to report earnings on Jan 01, 2026.

MLSS is expected to report earnings on Mar 27, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+1.44% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANGO($507M) has a higher market cap than MLSS($29.8M). ANGO YTD gains are higher at: 34.279 vs. MLSS (-60.448). ANGO has higher annual earnings (EBITDA): 1.79M vs. MLSS (-6.83M). ANGO has more cash in the bank: 38.8M vs. MLSS (1.27M). MLSS has less debt than ANGO: MLSS (1.09M) vs ANGO (5M). ANGO has higher revenues than MLSS: ANGO (301M) vs MLSS (9.08M).
ANGOMLSSANGO / MLSS
Capitalization507M29.8M1,701%
EBITDA1.79M-6.83M-26%
Gain YTD34.279-60.448-57%
P/E RatioN/AN/A-
Revenue301M9.08M3,314%
Total Cash38.8M1.27M3,046%
Total Debt5M1.09M460%
FUNDAMENTALS RATINGS
ANGO vs MLSS: Fundamental Ratings
ANGO
MLSS
OUTLOOK RATING
1..100
7533
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
98
Overvalued
PROFIT vs RISK RATING
1..100
95100
SMR RATING
1..100
9499
PRICE GROWTH RATING
1..100
3894
P/E GROWTH RATING
1..100
46100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANGO's Valuation (70) in the Medical Specialties industry is in the same range as MLSS (98). This means that ANGO’s stock grew similarly to MLSS’s over the last 12 months.

ANGO's Profit vs Risk Rating (95) in the Medical Specialties industry is in the same range as MLSS (100). This means that ANGO’s stock grew similarly to MLSS’s over the last 12 months.

ANGO's SMR Rating (94) in the Medical Specialties industry is in the same range as MLSS (99). This means that ANGO’s stock grew similarly to MLSS’s over the last 12 months.

ANGO's Price Growth Rating (38) in the Medical Specialties industry is somewhat better than the same rating for MLSS (94). This means that ANGO’s stock grew somewhat faster than MLSS’s over the last 12 months.

ANGO's P/E Growth Rating (46) in the Medical Specialties industry is somewhat better than the same rating for MLSS (100). This means that ANGO’s stock grew somewhat faster than MLSS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANGOMLSS
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 18 days ago
79%
Declines
ODDS (%)
Bearish Trend 9 days ago
71%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ANGO
Daily Signal:
Gain/Loss:
MLSS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NAUT1.890.16
+9.25%
Nautilus Biotechnolgy
CAPT0.880.03
+3.51%
Captivision
PFBC91.87-0.50
-0.54%
Preferred Bank
AMT181.13-2.22
-1.21%
American Tower Corp
LMND69.98-7.02
-9.12%
Lemonade

ANGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANGO has been loosely correlated with STRRP. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ANGO jumps, then STRRP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANGO
1D Price
Change %
ANGO100%
-2.84%
STRRP - ANGO
48%
Loosely correlated
-0.20%
MXCT - ANGO
36%
Loosely correlated
-4.43%
BLFS - ANGO
34%
Loosely correlated
-3.01%
MMSI - ANGO
33%
Poorly correlated
-0.82%
NVST - ANGO
32%
Poorly correlated
-1.14%
More

MLSS and

Correlation & Price change

A.I.dvisor tells us that MLSS and ANGO have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MLSS and ANGO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLSS
1D Price
Change %
MLSS100%
+6.03%
ANGO - MLSS
27%
Poorly correlated
-2.84%
ESTA - MLSS
26%
Poorly correlated
+2.47%
SRDX - MLSS
26%
Poorly correlated
+0.15%
QDEL - MLSS
25%
Poorly correlated
-1.81%
GKOS - MLSS
25%
Poorly correlated
-0.86%
More